At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
- December 23, 2024
Yale Cancer Answers with Dr. Michaela Dinan: Emerging Trends in Cancer Care Outcomes
- December 20, 2024
Tobacco 21 policies could avert more than half a million premature deaths
- December 20, 2024Source: MedPage Today
Sticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting
- December 20, 2024Source: NBC Connecticut
Here's how inflammation can affect the body
- December 20, 2024Source: WICC Radio
Melissa in the Morning: Waldenstrom's Macroglobulinemia
- December 20, 2024Source: HealthCentral
2024’s Biggest News in Non-Small Cell Lung Cancer Care
- December 20, 2024Source: Medscape
Trial of ctDNA-directed Breast Cancer Therapy Fizzles Out
- December 18, 2024
In Memoriam: David S. Fischer, MD
- December 18, 2024
Yale research advances presented at American Society of Hematology annual meeting
- December 18, 2024Source: Parade
'I'm a Doctor and Cancer Researcher at Yale, and This Is the One Thing I'm Begging You to Never, Ever Do'
- December 18, 2024Source: Newsweek
Cancer Dietitian Reveals Two Things She Tells People to Avoid Consuming
- December 17, 2024
YCC Publications 2024